B.Riley: 'We are aggressive buyers of Viking Therapeutics'

September 22, 2026 10:35 AM

B.Riley analyst Mayank Mamtani reiterated a Buy rating and $85.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found